| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | EP1368287B1 Process for a homogeneously catalyzed c-c coupling reaction |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 03/26/2008 | CN101151248A 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/26/2008 | CN101151239A Novel biaromatic compounds, inhibitors of the P2X7-receptor |
| 03/26/2008 | CN101148436A Catalytic synthesis method for pyridine base |
| 03/26/2008 | CN101148400A Method for preparing aldehydes and ketones by using oxygen gas to oxidize alcohols |
| 03/26/2008 | CN100376584C Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony and uses thereof |
| 03/26/2008 | CN100376572C Anti-infective agents |
| 03/26/2008 | CN100376565C Method for preparing fused oxazinones |
| 03/26/2008 | CN100376551C Semicarbazone synthesis method |
| 03/25/2008 | US7348456 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents |
| 03/25/2008 | US7348449 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348350 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesirable microorganisms |
| 03/25/2008 | US7348344 Polysubstituted 1,1-pyridyloxycyclopropanamine compounds |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008033455A2 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
| 03/20/2008 | WO2008032334A1 Eco-friendly process for recovery of pyridine and/or its derivatives |
| 03/20/2008 | WO2008032204A1 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 03/20/2008 | WO2008032156A1 Diaryl ether derivatives and uses thereof |
| 03/20/2008 | WO2008031811A1 Nitrate esters of aminoalcohols |
| 03/20/2008 | WO2008031734A1 5-phenyl-nicotinamide derivatives |
| 03/20/2008 | WO2008031534A1 Insecticidal compounds |
| 03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | WO2008031501A2 2-phenoxy nicotine acid derivative and use thereof |
| 03/20/2008 | WO2008031500A1 4-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators |
| 03/20/2008 | WO2008031199A1 Ionic compounds having bronsted acidity and uses thereof |
| 03/20/2008 | WO2008016692A3 Chemical compounds |
| 03/20/2008 | WO2008008954A3 Isothiocyanates and glucosinolate compounds and anti-tumor compositios containing same |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/20/2008 | WO2007138110A3 Compounds that interact with ion channels, in particular with ion channels from the kv family |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | WO2007072092A8 New phenanthridine derivatives as bradykinin antagonists |
| 03/20/2008 | US20080071047 Catalyst Composition And Use Thereof |
| 03/20/2008 | US20080070946 Hydroxymethylbenzothiazoles Amides |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070931 5-phenyl-nicotinamide derivatives |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070887 Diaryl Ether Derivatives and Uses Thereof |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070789 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 03/20/2008 | US20080069789 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663129A1 Nitrate esters of aminoalcohols |
| 03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 03/20/2008 | CA2662897A1 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 03/20/2008 | CA2662879A1 2-phenoxynicotinic acid derivatives and use thereof |
| 03/20/2008 | CA2662878A1 4-phenoxynicotinic acid derivatives and use thereof |
| 03/20/2008 | CA2662409A1 5-phenyl-nicotinamide derivatives |
| 03/19/2008 | EP1900740A1 Process for producing tricyclic ketone |
| 03/19/2008 | EP1900727A1 Aminopyridine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900726A1 Heterocyclic thioesters |
| 03/19/2008 | EP1900721A1 Substituted cyclic compound, its preparation process and its medical use |
| 03/19/2008 | EP1900367A2 Hypoglycemic agent |
| 03/19/2008 | EP1900366A2 Hypoglycemic agent |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899302A1 Phenoxy acetic acids as ppar delta activators |
| 03/19/2008 | EP1899301A1 Novel 3-aza-spiroý5.5¨undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | EP1899294A1 Therapeutic agents |
| 03/19/2008 | EP1283711B1 Peptide deformylase inhibitors |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | CN101146777A Carboxanilides as microbiocides |
| 03/19/2008 | CN101146775A Metabolites for nk-i antagonists for emesis |
| 03/19/2008 | CN101146774A Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 03/19/2008 | CN101146764A Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 03/19/2008 | CN101143844A Method of preparing milrinone lactate |
| 03/19/2008 | CN101143830A Organic electroluminescent material and application thereof |
| 03/19/2008 | CN100375740C Astaxanthin esters |
| 03/18/2008 | US7345177 Reacting beta -picoline with chlorine in the presence of a dealuminated Mordenite zeolite or a supported palladium catalyst to produce 2-Chloro-5-trichloromethylpyridine |
| 03/18/2008 | US7345176 Synthesis of nicotinamide from 3-cyanopyridine and isonicotinamide from 4-cyanopyridin using Manganese Dioxide as the catalyst; intermediates for tuberculosis drugs |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345172 Intercalation compound for use in the diagnosis and detection of genetic disorders; sterically demanding nucleotide intercalating compounds and methods for detecting base pair mismatches in nucleic acid sequences |
| 03/18/2008 | US7345129 resultant polymers exhibit improved performance and processing properties; especially of ethylene alone or the copolymerisation of ethylene with higher 1-olefins to provide homopolymers and copolymers having controllable molecular weights |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345059 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 03/18/2008 | US7345051 For controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infections |
| 03/18/2008 | CA2319359C Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008030843A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
| 03/13/2008 | WO2008030838A2 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2008030448A1 Phenethylamide derivatives with kinase inhibitory activity |
| 03/13/2008 | WO2008030266A2 Insecticidal n-substituted (heteroaryl)alkyl sulfilmines |
| 03/13/2008 | WO2008030158A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 03/13/2008 | WO2008030072A1 Compound for inhibiting the formation of beta-amyloid fibril, preparation thereof and pharmaceutical composition comprising same |
| 03/13/2008 | WO2008029912A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 03/13/2008 | WO2008029217A2 Dipeptidyl peptidase iv inhibitors |
| 03/13/2008 | WO2008029199A1 Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | WO2008028590A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |